Question reference: S6W-00850
- Asked by: Stuart McMillan, MSP for Greenock and Inverclyde, Scottish National Party
- Date lodged: 17 June 2021
-
Current status: Answered by Humza Yousaf on 14 July 2021
Question
To ask the Scottish Government what research is being carried out regarding the effectiveness of the COVID-19 vaccines on people who receive immunosuppressant medication.
Answer
The OCTAVE trial funded by the Medical Research Council (MRC) is a collaborative project involving the Universities of Birmingham, Glasgow, Oxford, Liverpool, Imperial College London and Leeds Teaching Hospitals NHS Trust. This research work is investigating the effectiveness of COVID-19 vaccines being used in the UK in 2021 in up to 5,000 people from certain clinically at-risk patient groups who have impaired immune system function through underlying disease or drug treatment.
Further information is available here:
- Vaccine responses studied in patients with impaired immune systems – UKRI
- University of Glasgow - Research - Coronavirus research - OCTAVE to study vaccine responses in patients with impaired immune systems .
The Joint Committee on Vaccination and Immunisation (JCVI) constantly review all published and unpublished data to inform vaccination policy recommendation. The JCVI have reviewed data already on this topic and will do so in an on-going basis.